Home›Companies›Biotech & Pharma›Prelude

Prelude Corp

Updated Oct 29, 2026·Latest SEC filing Nov 6, 2025·Suggest an edit

About Prelude

Prelude is a private company based in Laguna Hills, California. It has reported $40,931,163 raised in six offerings on Form D since March 2016.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 30, 2025Nov 6, 2025$5,000,000of $7.5M target1$5.0MDebt, OptionsRule 506(b)Form D ↗
Jan 31, 2022Feb 15, 2022$9,281,159of $20.0M target32$290KEquity, Options, Securities on exercise, Series F Preferred Stock and Warrants and the Common Stock issuable upon conversion thereof.Rule 506(b)Form D ↗
Dec 27, 2019Jan 10, 2020$10,000,013fully sold7$1.4MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Jul 20, 2018Jul 27, 2018$8,999,991fully sold7$1.2MEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 28, 2017Mar 15, 2017$5,499,998fully sold7$785KEquity, Options, Securities on exerciseRule 506(b)Form D ↗
Feb 26, 2016Mar 15, 2016$2,150,002of $3.0M target4$537KEquityRule 506(b)Form D ↗
Total, six offerings$40,931,163

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Prelude's Form D filed Nov 6, 2025.

GA
Gerrit Adams
Director
AW
Andrew Wade
Chief Financial Officer
Also CFO at Anaxiom.
OB
Olav Bergheim
Executive officer and director
Also an executive officer and director at Anaxiom.
DF
Daniel Forche
Executive officer and director
DM

Earlier filings also listed Hugh Neuharth (director, last listed Jan 2020) and William Link (director, last listed Jul 2018).

Sources

  1. SECPrelude Corp filing history